Antifungal Drugs: The Current Armamentarium and Development of New Agents
The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Abstract
Invasive fungal infections are becoming an increasingly important cause of human mortality and morbidity, particularly for immunocompromised populations. The fungal pathogens Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus collectively contribute to over 1 million human deaths annually. Hence, the importance of safe and effective antifungal therapeutics for the practice of modern medicine has never been greater. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for drug development remains limited. Only three classes of molecules are currently approved for the treatment of invasive mycoses. The efficacy of these agents is compromised by host toxicity, fungistatic activity, or the emergence of drug resistance in pathogen populations. Here we describe our current arsenal of antifungals and highlight current strategies that are being employed to improve the therapeutic safety and efficacy of these drugs. We discuss state-of-the-art approaches to discover novel chemical matter with antifungal activity and highlight some of the most promising new targets for antifungal drug development. We feature the benefits of combination therapy as a strategy to expand our current repertoire of antifungals and discuss the antifungal combinations that have shown the greatest potential for clinical development. Despite the paucity of new classes of antifungals that have come to market in recent years, it is clear that by leveraging innovative approaches to drug discovery and cultivating collaborations between academia and industry, there is great potential to bolster the antifungal armamentarium.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tolerance can be affected by several adjuvant drugs 12 , iron levels 26 , and genes involved in vacuolar protein sorting 19 , as well as calcium flux 14,27,28 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [12]
In the citing paper
“The current arsenal of antifungal compounds used for the treatment of aspergillosis consists of three classes of antifungal agents, two of them targeting ergosterol, the functional fungal analogue of cholesterol and the major component specific to fungal membranes, and a third class that targets the synthesis of β1,3 glucan, the major component of the fungal cell wall (610–614) (Fig. 20).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [613]
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953 · cited 1×
“cerevisiae genome are essential for viability (149).”
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationThe Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162 · cited 3×
“Combination therapy also has the potential to unveil myriad additional antifungal targets given that fungal biology is controlled by a highly interconnected and functionally redundant network of biological interactions (147, 148).”
Background
Research works printed but not linked: 1
- CDC. 2013. Antibiotic Resistance Threats in the United States 2013 . CDC Atlanta GA. [PubMed]
Cited by
Items 101–200 of 319
An Update on the Global Treatment of Invasive Fungal Infections
Munzen, M. E., Garcia, A. D. G., & Martinez, L. R. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0269 · Cited by 16
Chamel, S., Mishra, A., & Gull, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105545 · Cited by 16
Genomic Approaches to Antifungal Drug Target Identification and Validation
Robbins, N., & Cowen, L. E. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-094524 · Cited by 16
Self-citationLi, L., Wu, H., Zhu, S., Ji, Z., Chi, X., Xie, F., Hao, Y., Lu, H., Yang, F. J., Yan, L., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00794 · Cited by 16
Li, B. J., Wang, K., Zhang, R., Li, B., Shen, Y., & Ji, Q. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111669 · Cited by 16
Reese, S., Chelius, C. L., Riekhof, W. R., Marten, M. R., & Harris, S. D. (2021) · Journal of Fungi · doi:10.3390/jof7070525 · Cited by 15
Differential Effects of Linkers on the Activity of Amphiphilic Tobramycin Antifungals
Fosso, M. Y., Shrestha, S. K., Chandrika, N. T., Dennis, E. K., Green, K. D., & Garneau‐Tsodikova, S. (2018) · Molecules · doi:10.3390/molecules23040899 · Cited by 15
Host Defense Peptides as Templates for Antifungal Drug Development
Basso, V., Tran, D. Q., Ouellette, A. J., & Selsted, M. E. (2020) · Journal of Fungi · doi:10.3390/jof6040241 · Cited by 15
Vercelli, C., Peano, A., Piovano, G., Corona, A., Gambino, G., & Re, G. (2021) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2021.04.001 · Cited by 14
Interdisciplinary approaches for the discovery of novel antifungals
Yiu, B., Robbins, N., & Cowen, L. E. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.04.018 · Cited by 14
Self-citationInhibiting Protein Prenylation with Benzoxaboroles to Target Fungal Plant Pathogens
Kim, S. H., Liu, C., Zhou, Y., Zhang, Y., McGregor, C., Steere, L., Frederick, B. H., Liu, C. T., Whitesell, L. J., & Cowen, L. E. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00290 · Cited by 14
Self-citationŠtěpánek, O., Čmoková, A., Procházková, E., Grobárová, V., Černý, J., Slapničková, M., Zíková, A., Kolařík, M., & Baszczyňski, O. (2022) · ChemMedChem · doi:10.1002/cmdc.202200385 · Cited by 14
Advanced genetic techniques in fungal pathogen research
Ross, R. L., & Santiago-Tirado, F. H. (2024) · mSphere · doi:10.1128/msphere.00643-23 · Cited by 14
Galgóczy, L., & Marx, F. (2019) · Microorganisms · doi:10.3390/microorganisms7010016 · Cited by 14
Sathiyaseelan, A., Zhang, X., Han, K., & Wang, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131328 · Cited by 13
Kim, Y., Guk, T., Jang, M.-K., Park, S., & Lee, J. R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135402 · Cited by 13
Dahal, G. P., & Viola, R. E. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218767844 · Cited by 13
Calcineurin Inhibitors Synergize with Manogepix to Kill Diverse Human Fungal Pathogens
Liston, S. D., Whitesell, L., Kapoor, M., Shaw, K. J., & Cowen, L. E. (2022) · Journal of Fungi · doi:10.3390/jof8101102 · Cited by 12
Self-citationYassin, M. T., Mohamed, S., Al-Otibi, F. O., Maniah, K., & AbdelGawwad, M. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-20233-0 · Cited by 12
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2022) · F1000Research · doi:10.12688/f1000research.125645.1 · Cited by 12
Physical-chemical repurposing of drugs. History of its formation in Russia
Ураков, А. Л., & Shabanov, P. D. (2023) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf567782 · Cited by 12
Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses
Gómez-Gaviria, M., Contreras-López, L. M., Aguilera-Domínguez, J. I., & Mora-Montes, H. M. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s466336 · Cited by 12
Tancer, R. J., Pawar, S., Wang, Y., Ventura, C. R., Wiedman, G. R., & Xue, C. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00681 · Cited by 12
Lycorine Hydrochloride Inhibits the Virulence Traits ofCandida albicans
Yang, L., Liu, X., Sui, Y., Ma, Z., Feng, X., Wang, F., & Ma, T. (2019) · BioMed Research International · doi:10.1155/2019/1851740 · Cited by 12
Systemic and topical antifungal drugs
Borah, P., Hazarika, S., Sharma, D., Venugopala, K. N., Chopra, D., Al‐Shar’i, N. A., Hemalatha, S., Shakya, A. K., Acharya, P. C., & Deb, P. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90575-6.00002-8 · Cited by 12
Antifungal Activity of Bulgarian Rose Damascena Oil against Vaginitis‐Causing Opportunistic Fungi
Lee, Y., Park, E., Jang, B., Hwang, J., Lee, J., & Oh, E. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/5054865 · Cited by 11
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
Pedraza‐Sánchez, S., Cruz-González, A., Palmeros-Rojas, O., Gálvez-Romero, J. L., Bellanti, J. A., & Torres, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.987231 · Cited by 11
Zala, A. R., Rajani, D. P., & Kumari, P. (2023) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-023-02801-1 · Cited by 11
The Contribution of Human Antimicrobial Peptides to Fungi
Zhang, Q., Cai, J., Wang, X., Xi, L., & Lu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062494 · Cited by 10
Antiviral drug repurposing: different approaches and the case of antifungal drugs
Tuci, S., Mercorelli, B., & Loregian, A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108903 · Cited by 10
Hugar, A., & Nayaka, S. (2025) · The Microbe · doi:10.1016/j.microb.2025.100454 · Cited by 10
Fan, G., Xu, Z., Liu, X., Yin, W. H., Sun, L., Wu, D., Wei, M., Wang, W., & Cai, Y. (2023) · Natural Product Communications · doi:10.1177/1934578x221148607 · Cited by 10
Zhang, K., Sun, I. G., Liao, B., Yang, Y., Ma, H., Jiang, A., Chen, S., Guo, Q., & Ren, B. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106855 · Cited by 10
Araújo, G. R., da Costa, P. C. Q. G., Nogueira, P. L., Alves, D. D. N., Ferreira, A. R., da Silva, P. R., Andrade, J., de Sousa, N. F., Loureiro, P. B. A., Sobral, M. V., et al. (2024) · BioTech · doi:10.3390/biotech13020016 · Cited by 10
Ichikawa, Y., Bruno, V. M., Woolford, C. A., Kim, H., Do, E., Brewer, G. C., & Mitchell, A. P. (2021) · Genetics · doi:10.1093/genetics/iyab075 · Cited by 9
Liu, M.-Z., Dai, X.-H., Zeng, M.-T., & Chen, E. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12193-8 · Cited by 9
Puumala, E., Zaslaver, O., Chen, A., Duncan, D., Fogal, M., Shapiro, R. S., Mazhab‐Jafari, M. T., Whitesell, L. J., Montenegro-Burke, J. R., Robbins, N., et al. (2022) · mBio · doi:10.1128/mbio.02730-22 · Cited by 9
Self-citationCoelho, R. A., Figueiredo‐Carvalho, M. H. G., Almeida‐Silva, F., Rabello, V. B. D. S., de Souza, G. R., Sangenito, L. S., Joffe, L. S., dos Santos, A. L. S., Lourenço, M. C. D. S., Rodrigues, M. L., et al. (2023) · Journal of Fungi · doi:10.3390/jof9070753 · Cited by 9
Exploration of Baicalein-Core Derivatives as Potent Antifungal Agents: SAR and Mechanism Insights
Zhou, H., Yang, N., Li, W., Peng, X., Dong, J.-X., Jiang, Y., Yan, L., Zhang, D., & Jin, Y. (2023) · Molecules · doi:10.3390/molecules28176340 · Cited by 9
Human Fungal Pathogens: Diversity, Genomics, and Preventions
Fahliyani, S. A., Rastegari, A. A., Yadav, N., & Yadav, A. N. (2021) · Fungal biology · doi:10.1007/978-3-030-60659-6_16 · Cited by 9
Prevention and Management of Complications
Kanodia, A., Verma, H., Jain, A., Kalsotra, G., Kumari, S., Agrawal, S. K., Gautam, H., Kaushal, D., Gugliani, A., & Lodha, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6284-0_8 · Cited by 9
Ottaviano, E., Borghi, E., Giovati, L., Falleni, M., Tosi, D., Magliani, W., Morace, G., Conti, S., & Ciociola, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010904 · Cited by 9
The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species
(2024) · doi:10.1128/mbio.02502-24 · Cited by 8
Brennan-Krohn, T., Friar, L., Ditelberg, S., & Kirby, J. E. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00268-21 · Cited by 8
Gong, X., Zhou, Y., Qin, Q., Wang, B., Wang, L., Jin, C., & Fang, W. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.01138-24 · Cited by 8
Prusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 8
Fungal calcineurin complex as an antifungal target: From past to present to future
Li, X., Zhang, C., & Lü, L. (2022) · Fungal Biology Reviews · doi:10.1016/j.fbr.2022.10.003 · Cited by 8
Li, C. R., Meng, Y., Li, H., Du, W., Gao, X., Suo, C., Gao, Y., Ni, Y., Sun, T., Yang, S., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2244087 · Cited by 8
Jain, T., Mishra, P., Kumar, S., Panda, G., & Banerjee, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.994873 · Cited by 8
Wang, Y., He, Y., Cai, T., Lei, Z., Lei, W., Cao, Y., & Wu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27346 · Cited by 7
Kumar, A., Francis, A., Hans, S., & Thakur, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_8 · Cited by 7
Drug Interactions of Antifungal Agents: Clinical Relevance and Implications
Corrêa-Junior, D., Frasés, S., & Araújo, G. R. D. S. (2025) · Current Tropical Medicine Reports · doi:10.1007/s40475-024-00336-w · Cited by 7
Zheng, L., Dong, Y., Wang, J., Jia, Y., Wang, W., Xu, Y., & Guo, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1519323 · Cited by 7
Molecular recognition of fungal methylated glucosylceramides by ETD151 defensin
Kharrat, O., Paquet, F., Nasreddine, R., Madinier, J., Nehmé, R., Aucagne, V., Bulet, P., Warschawski, D. E., & Landon, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110587 · Cited by 7
Fluorescence Polarization‐Based Measurement of Protein‐Ligand Interaction in Fungal Cell Lysates
LeBlanc, E. V., Shekhar‐Guturja, T., Whitesell, L. J., & Cowen, L. E. (2021) · Current Protocols · doi:10.1002/cpz1.17 · Cited by 7
Self-citationMetzner, K., O’Meara, M. J., Halligan, B. S., Wotring, J. W., Sexton, J. Z., & O’Meara, T. R. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00503-23 · Cited by 7
Robbins, N., Ketela, T. W., Kim, S. H., & Cowen, L. E. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_10 · Cited by 7
Self-citationHachem, S. E., Fattouh, N., Chedraoui, C., Finianos, M., Bitar, I., & Khalaf, R. A. (2024) · Journal of Fungi · doi:10.3390/jof10050347 · Cited by 7
New Targets for the Development of Antifungal Agents
Spadari, C. D. C., Vila, T. V. M., Barroso, V. D. M., & Ishida, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21026-1 · Cited by 7
Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections
Kulkarni, N. A., & Nanjappa, S. G. (2024) · Vaccines · doi:10.3390/vaccines12090981 · Cited by 6
Yang, J., Wang, J., Liu, M., Zhou, X., Feng, D., Jiang, H., Liu, X., Chen, L., & Wang, Y. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60971-x · Cited by 6
Atanda, S. A., Shaibu, R. O., & Agunbiade, F. O. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-06828-2 · Cited by 6
Singh, S., Hans, S., Ahmad, A., Fatima, Z., & Hameed, S. (2022) · International Microbiology · doi:10.1007/s10123-022-00262-9 · Cited by 6
Cryptococcosis in oncology patients: a case series in a tertiary care cancer centre
Gangadharan, S. S., & Raveendranath, S. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i6.14163 · Cited by 6
Reginatto, P., Agostinetto, G. D. J., Teixeira, M. L., de Andrade, S. F., & Fuentefría, A. M. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101462 · Cited by 6
Prodrugging fungicidal amphotericin B significantly decreases its toxic effects
Štěpánek, O., Parigger, M., Procházková, E., Čmoková, A., Kolařík, M., Dračínská, H., Černá, V., Kalíková, K., Grobárová, V., Černý, J., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117157 · Cited by 6
CANDIDA sp, UMA BREVE REVISÃO BIBLIOGRÁFICA
de Melo, I. S. F., de Assis, E. C., Azevedo, M. B., Barbosa, T. S. S., & de Almeida, M. M. (2022) · RECISATEC - REVISTA CIENTÍFICA SAÚDE E TECNOLOGIA · doi:10.53612/recisatec.v2i5.129 · Cited by 6
Toxicology of Antifungal and Antiviral Drugs
Bano, S., Ahmedi, S., Manzoor, N., & Dey, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_24 · Cited by 6
Carbonic anhydrases from pathogens
Bonardi, A., Gratteri, P., & Nocentini, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816476-1.00019-8 · Cited by 6
Characterization of a New Hsp110 Inhibitor as a Potential Antifungal
Sun, C., Li, Y., Kidd, J. M., Han, J., Ding, L., May, A. E., Zhou, L., & Liu, Q. (2024) · Journal of Fungi · doi:10.3390/jof10110732 · Cited by 5
Overcoming Candida albicans biofilm drug resistance via azole-sophorolipid synergy
Jayasekara, L. A. C. B., Watchaputi, K., Butkinaree, C., & Soontorngun, N. (2026) · Scientific Reports · doi:10.1038/s41598-026-36278-8 · Cited by 5
Araujo, G. S., de Jesus, I. C. T. A., da Costa, P. C. Q. G., Marques, K. K. G., Gonçalves, J. C. R., & de Castro, R. D. (2026) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2026.106572 · Cited by 5
Han, M., Xia, Z., Zou, Y., Hu, P., Zhang, M., Yang, X., Ma, M., & Rong-ya, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s474299 · Cited by 5
Comprehensive review of fungal pathogenesis and antifungal therapeutics
Neog, B. R., Das, J., Das, B., Pathak, K., Sahariah, M., Saikia, R., & Sahariah, J. J. (2025) · Discover Medicine · doi:10.1007/s44337-025-00297-7 · Cited by 4
Abrantes, P. M. D. S., Stuurman, K. C., Klaasen, J. A., & Africa, C. W. J. (2024) · Europe PMC (PubMed Central) · doi:10.22034/cmm.2024.345240.1541 · Cited by 4
Qian, W., Liu, N., Lu, J., Liu, Q., Chen, S., & Wang, T. (2025) · Virulence · doi:10.1080/21505594.2025.2543981 · Cited by 4
Transferosomes As A Promising Platform for Targeted Antifungal Drug Delivery
Jain, Y., Jain, G., Dutta, D., & Yadav, M. (2025) · Current Fungal Infection Reports · doi:10.1007/s12281-025-00510-1 · Cited by 4
The role and possible mechanism of intestinal fungi in the progression of chronic liver diseases
Hu, Y. H., Yang, Y., Wang, S., & Chu, H. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00961-5 · Cited by 4
Slezina, M. P., & Odintsova, T. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104219 · Cited by 4
Reversal of Azole Resistance in Candida albicans by Human Neutrophil Peptide
Khan, M. I., Choudhry, H., Jahan, S., & Rather, I. A. (2023) · Biomedicines · doi:10.3390/biomedicines11020513 · Cited by 4
The therapeutic potential of phage-based antifungal treatment: strategies, mechanisms, and prospects
Xiao, H., Xie, J., Luo, Z., Yu, X., Zeng, J., & Li, Y. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2572805 · Cited by 4
Gazzinelli, B. P., Brêtas, C. M., & César, I. C. (2021) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmab064 · Cited by 4
Matthaiou, E. I., Chiu, W., Conrad, C., & Hsu, J. L. (2022) · Journal of Fungi · doi:10.3390/jof8070751 · Cited by 4
Screening and Synthesis of Tetrazole Derivatives that Inhibit the Growth of Cryptococcus Species
Nakada, N., Miyazaki, T., Mizuta, S., Hirayama, T., Nakamichi, S., Takeda, K., Mukae, H., Kohno, S., & Tanaka, Y. (2023) · ChemMedChem · doi:10.1002/cmdc.202300157 · Cited by 4
Li, T., Liu, Z., Fan, L., Zhang, Z., Bai, H., Wang, F., Shang, C., Zong, X., & Liu, Y. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02987-7 · Cited by 4
Lokhande, S. R., Adole, V. A., Rajesh, R., Mali, S. N., Sadgir, N. V., Islam, M. S., Almutairi, T. M., Cruz, J. N., Patil, M. P., & Jagdale, B. S. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141761 · Cited by 4
Antifungal Structure–Activity Relationship Studies of Broad-Spectrum Phenothiazines
Brosend, S. C., Guin, S., Giovine, G., Gadalla, C., Campos, M. A., Mara, A., Jentsch, N. G., Thakellapalli, H., Alden, K. M., Beattie, S. R., et al. (2025) · ACS Omega · doi:10.1021/acsomega.4c09833 · Cited by 4
Benelli, J. L., Poester, V. R., Munhoz, L. S., Klafke, G. B., Stevens, D. A., & Xavier, M. O. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-021-00552-w · Cited by 4
Uribe, B., González, O., Ourliac‐Garnier, I., Pape, P. L., Ba, B. B., Alonso, R. M., & Gaudin, K. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113366 · Cited by 4
Synthesis and antifungal evaluation against Candida spp. of the (E)-3-(furan-2-yl)acrylic acid
da Costa, P. C. T., Santos, T. L. B., Ramos, J. F., Santos, J. A. M., de Medeiros, F. D., Freitas, J. C. R., & de Oliveira, W. A. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-01158-0 · Cited by 3
Zheng, C., Zhang, X., Ma, Y., & Zhang, Y. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2025.101549 · Cited by 3
Meng, X., Zhao, Y., Xiang, Q., Wu, J., Gong, X., Wang, Y., Chen, L., & Zhang, P. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166603 · Cited by 3
Lu, X.-R., Wang, R., Yu, Y., Wei, J., Xu, Y., Zhou, L., Mao, F., Li, J., Li, X., & Jia, X. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02453 · Cited by 3
Antifungal Resistance in Candida albicans
Seyedjavadi, S. S., Hatami, F., & Jahanshiri, Z. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004578 · Cited by 3
Chakraborty, S., Pawaskar, A., Metkari, S., Madan, T., & Idicula‐Thomas, S. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70138 · Cited by 3
Waykar, R. G., & Kumarapillai, S. (2024) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.15.3.33 · Cited by 3
Silva, I., Maltarollo, V. G., Protti, Í. F., de Oliveira, R. C., & César, I. C. (2022) · Journal of the Brazilian Chemical Society · doi:10.21577/0103-5053.20220131 · Cited by 3
Soontorngun, N., Somboon, P., & Watchaputi, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-21110-3_13 · Cited by 3
Ferrão, S. K. (2020) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 3
Metadata
- Authors
- Robbins, N., Wright, G. D., & Cowen, L. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- University of Toronto (CA)
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2016-10-14
- Volume
- 4
- Issue
- 5
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2532305189
- Cited by
- 271
- References
- 182
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 22 · 2021: 29 · 2020: 27 · 2019: 17 · 2018: 10 · 2017: 5
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal agents, invasive fungal infections, antifungal resistance, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, antifungal drug development, antifungal drug targets, combination antifungal therapy, drug toxicity, immunocompromised patients, novel antifungal agents
- MeSH terms
- Animals, Antifungal Agents, Fungi, Humans, Mycoses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.